Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Virol. 1996 Dec;70(12):8747-51.

Herpes simplex virus type 2 inhibition of Fas ligand expression.

Author information

  • 1Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106-4943, USA.

Abstract

Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are common human pathogens. In this report we demonstrate the capacity of HSV-2, but not HSV-1, to inhibit the activity and cell surface expression of Fas ligand, an important molecule involved in T-cell apoptosis and cell-mediated cytotoxicity. Cells infected with HSV-2 retained Fas ligand intracellularly instead of expressing it on the cell surface. Addition of anti-Fas antibodies markedly inhibited HSV-2 viral production, suggesting that the capacity of the virus to regulate Fas ligand expression, and thereby programmed cell death, may represent a powerful mechanism for the virus to enhance viral replication.

PMID:
8971002
[PubMed - indexed for MEDLINE]
PMCID:
PMC190970
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk